Bill Targets tax credit given to orphan drug companies

The new Republican tax bill, which was unveiled on Thursday, proposes to get rid of tax credits that are used to develop rare disease drugs. Under current policy, pharmaceutical and biotech companies are allowed a tax credit of up to 50% of certain research costs for rare disease drugs.

Leave a Reply